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Abstract Prostaglandin (PG) E2 release is induced in pulmo-
nary A549 cells by the NF-UB-activating stimuli interleukin-1L
(IL-1L) and phorbol 12-myristate 13-acetate (PMA). Adenovi-
ral over-expression of IUBKvN, a dominant NF-UB inhibitor,
prevents NF-UB-dependent transcription and was used to qualify
the role of NF-UB in the release of PGE2. IUBKvN repressed
IL-1L-induced, but not PMA-induced, cycloxygenase-2 (COX-
2) and microsomal prostaglandin E synthase (mPGES) expres-
sion. These data conclusively demonstrate a substantial role for
NF-UB in the co-ordinate induction of COX-2, mPGES and in
the corresponding release of PGE2 by IL-1L. However, other
pathways are primarily responsible for PGE2 release induced by
PMA.
4 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Prostaglandins (PGs) are implicated in normal cellular pro-
cesses as well as pathophysiologically in in£ammation, oede-
ma, bronchoconstriction, fever and hyperalgesia [1]. PG syn-
thesis requires conversion of arachidonic acid to PGH2 either
by the constitutive cyclooxygenase (COX) 1 or by COX-2,
which is induced by in£ammatory and mitogenic stimuli [1].
Subsequently, PGE2 is produced by two prostaglandin E syn-
thases (PGESs). The microsomal glutathione-dependent
PGES (mPGES) [2] is functionally linked to COX-2, whereas
the cytosolic PGES is coupled to COX-1 [3,4]. As the target of
non-steroidal anti-in£ammatory drugs (NSAIDs), this path-
way is of great pharmacological importance and it is believed
that the anti-in£ammatory bene¢ts of NSAIDs derive from
COX-2 inhibition [1]. However, the inhibition of COX-2
may also exacerbate in£ammation by a¡ecting resolution [5].
The transcription factor nuclear UB (NF-UB) regulates nu-
merous in£ammatory genes and is considered as a possible
target for therapeutic intervention [6]. Various studies have
implicated NF-UB in the transcriptional regulation of COX-
2 using reporter-based assays [7^10], inhibitors [11^15], anti-
sense [16] or decoy oligonucleotides [9]. However, an unequiv-
ocal demonstration of a role for NF-UB in in£ammatory PG
synthesis is currently lacking and the ATF/CRE and C/EBP
sites are cited as the main regulators of COX-2 promoter
activity [1]. In pulmonary A549 cells, COX-2 is transcription-
ally induced by interleukin (IL) 1L and NF-UB (p50/p65)
binds to putative NF-UB sites from the human COX-2 pro-
moter [17]. As mPGES is also up-regulated by in£ammatory
stimuli [2,18,19], we have used A549 cells and adenoviral-
mediated over-expression of IUBKvN, a dominant inhibitor
of NF-UB [20], to unequivocally address the role of NF-UB
in these processes.
2. Materials and methods
2.1. Cell culture and adenoviral infection
A549 cells were grown as described in [21]. Ad5 adenoviral vectors
were: a green £uorescent protein (GFP) expressing vector, Ad5-GFP
(QBioGene-Alexis, Nottingham, UK), Ad5-IUBKvN (HepaVec, Ber-
lin, Germany), which contains an RSV promoter driving expression of
an N-terminally deleted IUBK [20], and an empty Ad5-RSV vector
(Null). Pre-con£uent cells were infected with adenoviral vectors at
the indicated multiplicity of infection (MOI) and incubated overnight
prior to washing and changing to fresh serum-containing medium.
Following overnight incubation, cells were treated 48 h after adeno-
viral infection by changing to fresh medium or media containing 1 ng/
ml IL-1L (RpD Systems, Abingdon, UK) or 1U1037 M phorbol
12-myristate 13-acetate (PMA) (Sigma, Poole, UK) as indicated. Cells
grown on coverslips were ¢xed with 4% paraformaldehyde and
stained with 1 WM 4P,6P-diamidino-2-phenylinole dihydrochloric hy-
drate (DAPI) (Sigma) prior to analysis by confocal £uorescent mi-
croscopy using a Leica confocal microscope equipped with a 488 and
514 dual-band argon laser and TCS NT software for the capture of
images (Leica Microsystems, Milton Keynes, UK).
2.2. Analysis of NF-UB DNA binding, NF-UB-dependent transcription
and IUBK protein
Electromobility shift assay (EMSA) and the use of the NF-UB-de-
pendent reporter cells, 6UBtk.luc A549s, was as described in [22,23].
0014-5793 / 03 / $22.00 K 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
doi:10.1016/S0014-5793(03)00672-0
*Corresponding author. Fax: (44)-24-76523701.
E-mail address: robert.newton@ic.ac.uk (R. Newton).
Abbreviations: COX, cyclooxygenase; DAPI, 4P,6P-diamidino-2-phe-
nylinole dihydrochloric hydrate; EMSA, electrophoretic mobility shift
assay; GFP, green £uorescent protein; IL, interleukin; mPGES,
microsomal PGES; MOI, multiplicity of infection; NF-UB, nuclear
factor UB; NSAID, non-steroidal anti-in£ammatory drug; PG, pros-
taglandin; PGES, prostaglandin E synthase; PMA, phorbol 12-my-
ristate 13-acetate
FEBS 27423 4-7-03 Cyaan Magenta Geel Zwart
FEBS 27423 FEBS Letters 547 (2003) 75^79
Western blot analysis using SDS^PAGE and standard transfer proto-
cols was carried out using an antiserum speci¢c for the serine 32
phosphorylated form of IUBK (#9240) (New England Biolabs, Hitch-
in, UK) and total IUBK (Sc-371) (Santa Cruz, CA, USA).
2.3. Analysis of PGE2 release, COX-2 and PGES expression
PGE2 in culture media was measured by radioimmunoassay (RIA)
using an anti-PGE2 antibody (Sigma) according to the manufacturer’s
instructions as described in [21]. Northern blot and Western blot
analysis was as described in [21]. Antibodies for Western analysis
were COX-2 C20 epitope (Santa Cruz) and mPGES (Cayman).
2.4. Densitometry and statistical analysis
Densitometric analysis of X-ray ¢lms from Western blot analysis,
following ECL (Amersham) visualisation, or Northern blot hybrid-
isation, following autoradiography, was performed below the satura-
tion level of the ¢lm using TotalLab software (Nonlinear Dynamics,
Newcastle upon Tyne, UK). In all cases statistical analysis was per-
formed using analysis of variance with a Bonferroni post-test and
graphical data are presented as meansRS.E.M.
3. Results
3.1. Infection of A549 cells with Ad5 expression vectors
A549 cells were infected with various MOIs of a GFP-ex-
pressing Ad5 construct. Following DAPI staining of nuclei,
the presence of GFP was analysed by confocal £uorescence
microscopy (Fig. 1). Below a MOI of 0.1, only low numbers
(6 7.5%) of GFP-positive cells were observed (data not
shown). Between MOIs of 0.1 and 10 a concentration-depen-
dent increase in GFP-positive cells was observed (Fig. 1). At a
MOI of 10, V90% of cells were positive for GFP and no
signi¢cant e¡ect on cell viability was observed as determined
by MTT cell viability assay (Fig. 1 and data not shown).
3.2. IUBKvN inhibits NF-UB-dependent transcription and
DNA binding
The IUBKvN derivative of IUBK is a dominant inhibitor of
NF-UB by virtue of the N-terminal (1^70) deletion of the
region containing the serine residues, S32 and S36 [20]. Anal-
ysis of the NF-UB-dependent reporter cell line, 6UBtk A549,
revealed robust responses to both IL-1L and PMA, whilst
increasing MOI of Ad5-IUBKvN decreased luciferase activity
in a concentration-dependent manner (Fig. 2A). Western blot
analysis con¢rmed increased expression of IUBKvN with in-
creasing viral titre and demonstrated that this was inversely
related to the expression of endogenous NF-UB-dependent
gene, IUBK (Fig. 2A) [24]. These data therefore provide func-
tional validation of the e¡ectiveness of NF-UB inhibition.
Analysis of NF-UB DNA binding revealed a strong re-
sponse to IL-1L and a considerably weaker response to
PMA (Fig. 2B,C). These data are consistent with our previous
¢ndings and raise the possibility that the activation of NF-UB
by PMA occurs via a mechanistically distinct process [25]. As
in previous studies [22,25], we ¢nd the induction of two pre-
dominant DNA binding complexes, which were both previ-
ously shown to contain p50 (NF-kB1) and p65 (RelA) sub-
units [25]. In each case, prior infection with an empty Ad5
vector (Null) had little e¡ect on either basal or stimulated
levels of NF-UB DNA binding, whereas infection with Ad5-
IUBKvN at MOI 10 reduced NF-UB DNA binding to below
basal levels (Fig. 2B,C).
To examine the possibility that IL-1L and PMA were caus-
ing activation of distinct signalling pathways, cells treated
with each stimulus were subjected to Western blot analysis
for both the phosphorylated form of IUBK as well as total
IUBK (Fig. 2D). In the case of IL-1L stimulation, a strong
increase in IUBK phosphorylation was observed at 5 and
15 min post-stimulation. This was closely followed by the
near-complete loss of IUBK within 15 min and then a gradual
reappearance 1 h later. By contrast, stimulation with PMA
produced no obvious increase in IUBK phosphorylation and
no loss due to signal-induced degradation. Thus these data
suggest that whilst the IKK pathway leading to IUBK phos-
phorylation and degradation is strongly activated by IL-1L,
there is no such response to PMA. It is therefore likely that
the transcriptional activation by PMA is occurring via other
mechanisms.
3.3. E¡ect of IUBKvN on COX-2 expression
A549 cells were infected with Ad5-IUBKvN and null virus
(as above). As IL-1L-induced COX-2 mRNA is maximal at
4^6 h post-stimulation, cells were harvested at 6 h for North-
ern blot analysis [21]. COX-2 mRNA expression was signi¢-
cantly increased by both IL-1L and PMA (both P6 0.001)
(Fig. 3A). In each case the null virus alone had no signi¢cant
e¡ect on COX-2 expression, whereas IL-1L-induced COX-2
mRNA, but not PMA-induced COX-2 mRNA, was signi¢-
cantly reduced by Ad5-IUBKvN (P6 0.001 for IL-1L vs
IL-1L+IUBKvN and P6 0.05 for IL-1L+Null virus vs
Fig. 1. Infection of A549 cells with GFP-expressing adenovirus.
Cells were incubated overnight in serum containing medium with
various MOIs of Ad5.CMV-GFP prior to changing to fresh me-
dium. At 48 h post-infection cells were stained with DAPI prior to
analysis by confocal microscopy. DAPI-stained nuclei (left panels)
and GFP £uorescence (right panels) are shown for MOI 0 and 10.
Cells showing any GFP £uorescence were counted as positive. Data
from ¢ve such experiments were expressed as a percentage of the to-
tal cell number and are plotted as meansRS.E.M.
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IL-1L+IUBKvN) (Fig. 3A). Consistent with these data, West-
ern blot analysis of COX-2 protein expression showed a near-
identical pro¢le with the IUBKvN virus causing signi¢cant
repression of IL-1L-induced COX-2 when compared to either
the IL-1L-treated samples (P6 0.001) and the IL-1L+null vi-
rus samples (P6 0.01) (Fig. 3B). Whilst in each case some
degree of repression of PMA-stimulated COX-2 by IUBKvN
virus was apparent, this did not reach signi¢cance.
3.4. E¡ect of IUBKvN over-expression on mPGES expression
and PGE2 release
Western blot analysis for mPGES at 24 h post-stimulation
revealed levels of mPGES that were induced around two-fold
by both IL-1L (P6 0.05) and PMA (Fig. 3C). The null
Ad5 expression vector showed no e¡ect on mPGES, whilst
the Ad5-IUBKvN virus reduced basal expression and pre-
vented the induction by IL-1L (P6 0.05 for IL-1L vs
IL-1L+IUBKvN). Again, the PMA-dependent response was
essentially una¡ected.
In A549 cells, PGE2 is the principal PG produced [26].
Supernatants from the above experiments were therefore
analysed for the presence of PGE2. Unstimulated cells pro-
duced only low to undetectable levels of PGE2 (0.09R 0.05 ng/
ml), whilst IL-1L and PMA resulted in signi¢cantly elevated
elaboration of PGE2 (3.99R 0.82 and 2.19R 0.56 ng/ml with
P6 0.001 and 6 0.05, respectively) (Fig. 3C, lower panel).
The null virus had no obvious e¡ect on PGE2 release, whilst
viral expression of IUBKvN resulted in a near-complete loss
of PGE2 from IL-1L-treated (P6 0.001 for IL-1L vs
IL-1L+IUBKvN and P6 0.05 for IL-1L+null virus vs
IL-1L+IUBKvN), but not from PMA-treated cells (Fig. 3C,
lower panel).
4. Discussion
A number of promoter-based studies have variously impli-
cated the C/EBP, CRE/ATF and NF-UB binding sites in the
transcriptional activation of the COX-2 promoter [7^9,27,28].
In this report, we provide compelling evidence for a major
role of the transcription factor NF-UB in the induction of
COX-2 mRNA, protein and the subsequent release of PGE2
in response to IL-1L in human pulmonary A549 cells. These
data are consistent with previous data showing an eight-fold
induction of COX-2 transcription rate by IL-1L in A549 cells
and with promoter-based studies implicating NF-UB in the
activation of the COX-2 promoter in other cell lines [7,9,17].
By contrast, the induction of COX-2 expression by the phor-
bol ester, PMA, was essentially independent of NF-UB acti-
vation. As PMA is known to induce pathways leading to AP-
1 and ATF transcriptional activation, it is likely that this
response is primarily occurring via the CRE/ATF site as has
been suggested for v-src-dependent induction of COX-2 [28].
In this respect, we also note that the PMA-dependent path-
way that leads to activation of NF-UB-dependent transcrip-
tion in these cells does not primarily appear to involve IKK-
dependent phosphorylation of IUBK and is therefore mecha-
nistically distinct from activation by IL-1L. Further studies
are necessary to explore this result.
In addition to association and coordinate regulation with
COX-2, the downstream mPGES gene is functionally linked
Fig. 2. Over-expression of IUBKvN inhibits NF-UB-dependent transcription and NF-UB DNA binding. A549 6UBtk cells were either not in-
fected or were infected with various MOI of Ad5-IUBKvN virus. A: Cells were either not stimulated (NS) or stimulated with IL-1L (1 ng/ml)
or PMA (1037 M) for 6 h prior to harvesting for Western blot analysis and luciferase determination. Blots representative of three such experi-
ments using an antiserum (IUBK C21) that detects a C-terminal epitope on IUBK are shown. Luciferase data from four such experiments were
expressed as a percentage of the stimulus and plotted as meansRS.E.M. B: A549 cells were either not infected or infected at a MOI of 10
with either Ad5-IUBKvN or null virus as indicated. After changing to serum-free media, cells were either not stimulated (NS) or treated with
IL-1L (1 ng/ml) or PMA (1037 M). Cells were harvested after 1 h and nuclear proteins prepared for EMSA analysis of NF-UB DNA binding.
An autoradiograph representative of four such experiments is shown. The two speci¢c DNA binding complexes were identi¢ed by cold competi-
tion and are indicated. Free probe is indicated. C: Autoradiographs (n=4) from experiments in panel B were subjected to densitometric analy-
sis and optical densities were plotted as meansRS.E.M. D: Cells stimulated with either IL-1L or PMA were harvested at the times indicated
and subjected to sequential Western blot analysis for the serine 32 phosphorylated form of IUBK and total IUBK. Blots representative of two
such experiments are shown.
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to the production of PGs via the COX-2 pathway and may be
induced by in£ammatory stimuli, including IL-1L
[3,4,18,19,29]. Previous studies have implicated binding of
the transcription factor Egr-1 to GC boxes located close to
transcription start in the transcriptional activation of the
mouse mPGES promoter by PMA and IL-1L+TNFK [30].
By contrast, the data reported here support a role for
NF-UB in the induction of the human mPGES gene in A549
cells in response to IL-1L. In common with the e¡ect on
COX-2, phorbol ester-induced mPGES appears to be indepen-
dent of NF-UB and could therefore be more reliant on GC
box binding factors. Further promoter analyses will be re-
quired to address the location of NF-UB-responsive sites
and the possible role of the GC boxes in the human mPGES
promoter.
Taken together, the data reported here indicate a major role
for the transcription factor NF-UB in the co-ordinate regula-
tion of the COX-2/mPGES pathway in the production of
PGE2 in in£ammatory situations. Given the intense interest
in the pharmacological inhibition of NF-UB as a therapeutic
target in in£ammatory diseases such as asthma, these data
certainly demonstrate, like the e¡ect of glucocorticoids, the
e⁄cacy of inhibiting NF-UB to prevent in£ammatory gene
expression. However, the existence of conditions such as as-
pirin-sensitive asthma and the fact that COX-2 may play a
role in resolution of in£ammation indicates that not all the
e¡ects of NF-UB inhibition are necessarily bene¢cial in dis-
eases such as asthma [5]. Further studies therefore are re-
quired to e¡ectively weigh up the relative bene¢ts and adverse
e¡ects of NF-UB inhibitors as novel anti-in£ammatory agents.
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